These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3894278)
1. A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer. Allegra JC; Woodcock T; Woolf S; Henderson IC; Bryan S; Reisman A; Dukart G Invest New Drugs; 1985; 3(2):153-61. PubMed ID: 3894278 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study). Cowan JD; Osborne CK; Neidhart JA; Von Hoff DD; Constanzi JJ; Vaughn CB Invest New Drugs; 1985; 3(2):149-52. PubMed ID: 3894277 [TBL] [Abstract][Full Text] [Related]
3. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Bennett JM; Byrne P; Desai A; White C; DeConti R; Vogel C; Krementz E; Muggia F; Doroshow J; Plotkin D Invest New Drugs; 1985; 3(2):179-85. PubMed ID: 3894279 [TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745 [TBL] [Abstract][Full Text] [Related]
5. A comparison of mitoxantrone and doxorubicin in breast cancer. Neidhart JA; Gochnour D; Roach R; Hoth D; Young D J Clin Oncol; 1986 May; 4(5):672-7. PubMed ID: 3517241 [TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study. Mouridsen HT; Cornbleet M; Stuart-Harris R; Smith I; Coleman R; Rubens R; McDonald M; Rainer H; van Oosterom A; Smyth J Invest New Drugs; 1985; 3(2):139-48. PubMed ID: 4019118 [TBL] [Abstract][Full Text] [Related]
7. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas. De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006 [TBL] [Abstract][Full Text] [Related]
8. First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer. Periti P; della Cuna GR; Pannuti F; Mazzei T; Preti P; Martoni A; Mini E Invest New Drugs; 1985; 3(2):167-71. PubMed ID: 4019120 [TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer. Holmes FA; Yap HY; Esparza L; Buzdar AU; Hortobagyi GN; Blumenschein GR Semin Oncol; 1984 Sep; 11(3 Suppl 1):28-31. PubMed ID: 6385262 [TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial. Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877 [No Abstract] [Full Text] [Related]
11. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer. Metz R; Delgado M; Keiling R; Cappelaere P; Armand JP; Prevot G; Misset JL; Grimbert J; Mathe G Invest New Drugs; 1985; 3(2):163-6. PubMed ID: 4019119 [TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: an overview of safety and toxicity. Posner LE; Dukart G; Goldberg J; Bernstein T; Cartwright K Invest New Drugs; 1985; 3(2):123-32. PubMed ID: 3894276 [TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone: a replacement for doxorubicin? Conner CS Drug Intell Clin Pharm; 1984 Jun; 18(6):479-80. PubMed ID: 6734434 [TBL] [Abstract][Full Text] [Related]
14. A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancer. Neidhart JA; Gochnour D; Roach RW; Young D; Steinberg JA Semin Oncol; 1984 Sep; 11(3 Suppl 1):11-4. PubMed ID: 6385259 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study. Cowan JD; Neidhart J; McClure S; Coltman CA; Gumbart C; Martino S; Hutchins LF; Stephens RL; Vaughan CB; Osborne CK J Natl Cancer Inst; 1991 Aug; 83(15):1077-84. PubMed ID: 1875415 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update. Benjamin RS; Chawla SP; Ewer MS; Carrasco CH; Mackay B; Holmes F Invest New Drugs; 1985; 3(2):117-21. PubMed ID: 4019116 [TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients. Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT; Smyth JF Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1141-6. PubMed ID: 6541135 [TBL] [Abstract][Full Text] [Related]
18. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma. Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953 [TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone as a first-line treatment of advanced breast cancer. Landys K; Borgstrom S; Andersson T; Noppa H Invest New Drugs; 1985; 3(2):133-7. PubMed ID: 4019117 [TBL] [Abstract][Full Text] [Related]
20. First-line mitoxantrone chemotherapy for advanced breast cancer. Wilson KS; Paterson AH Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]